Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage)

This study has been completed.
Information provided by (Responsible Party):
S.F. Oosting, University Medical Centre Groningen Identifier:
First received: December 8, 2009
Last updated: January 27, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)